Targeted drug combinations: avant-garde oncology

Por Dan, Tu D., Palmer, Joshua D.
Publicado no Ann Transl Med (2015)

Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer

Por Palmer, Joshua D., Zaorsky, Nicholas G., Witek, Matthew, Lu, Bo
Publicado em 2014

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Por Cai, Gang, Zhu, Ji, Palmer, Joshua D, Xu, Ye, Hu, Weigang, Gu, Weilie, Cai, Sanjun, Zhang, Zhen
Publicado no Radiat Oncol (2015)

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy

Por Alexander, Gregory S., Palmer, Joshua D., Tuluc, Madalina, Lin, Jianqing, Dicker, Adam P., Bar-Ad, Voichita, Harshyne, Larry A, Louie, Jennifer, Shaw, Colette M., Hooper, D. Craig, Lu, Bo
Publicado no J Hematol Oncol (2016)